Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Retained Earnings (2019 - 2025)

IDEAYA Biosciences' Retained Earnings history spans 7 years, with the latest figure at -$736.5 million for Q4 2025.

  • For Q4 2025, Retained Earnings fell 18.25% year-over-year to -$736.5 million; the TTM value through Dec 2025 reached -$736.5 million, down 18.25%, while the annual FY2025 figure was -$736.5 million, 18.25% down from the prior year.
  • Retained Earnings for Q4 2025 was -$736.5 million at IDEAYA Biosciences, down from $2.1 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $3.8 million in Q3 2024 and bottomed at -$772.5 million in Q2 2025.
  • The 5-year median for Retained Earnings is -$183.8 million (2021), against an average of -$239.2 million.
  • The largest annual shift saw Retained Earnings crashed 2525071.43% in 2021 before it skyrocketed 101.22% in 2024.
  • A 5-year view of Retained Earnings shows it stood at -$176.7 million in 2021, then surged by 98.38% to -$2.9 million in 2022, then tumbled by 12033.89% to -$348.4 million in 2023, then crashed by 78.79% to -$622.8 million in 2024, then dropped by 18.25% to -$736.5 million in 2025.
  • Per Business Quant, the three most recent readings for IDYA's Retained Earnings are -$736.5 million (Q4 2025), $2.1 million (Q3 2025), and -$772.5 million (Q2 2025).